TrialClinical pharmacokinetics2003

Influence of severe renal impairment on the pharmacokinetics and pharmacodynamics of oral ximelagatran and subcutaneous melagatran.

Ulf G Eriksson et al.PubMed ↗Publisher ↗

No numbers read from the abstract.